Inventory increased 161.0%
Inventory changed +161.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +161.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +38.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +43.5% from the comparable as-filed period.
Operating income changed +125.8% from the comparable as-filed period.
Revenue changed +58.1% from the comparable as-filed period.
Operating margin changed +568 basis points from the comparable as-filed period.
Operating cash flow changed +41.2% from the comparable as-filed period.
Cash & equivalents changed -53.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current liabilities changed +55.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +57.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +58.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed -40.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Selling, general & administrative changed +33.1% from the comparable as-filed period.
Inventory / revenue changed +1489 basis points from the comparable as-filed period.
Cost of revenue changed +37.0% from the comparable as-filed period.
Research & development changed +35.7% from the comparable as-filed period.
Gross margin changed +149 basis points from the comparable as-filed period.
Stock-based compensation changed +28.8% from the comparable as-filed period.
Capital expenditure changed -73.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +737 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed -1785 basis points from the comparable as-filed period.
Operating cash-flow margin changed -199 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -169 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -190 basis points from the comparable as-filed period.
SBC / revenue changed -104 basis points from the comparable as-filed period.
Capex / revenue changed -31 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed +1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.